CFO and CTO, Steven Timcke & Alfonso Ferrandez, join OIA to strengthen its leadership & management team

As part of our ongoing commitment to professionalising and strengthening our leadership team, we are delighted to introduce Steven Timcke, OIA’s Chief Financial Officer (CFO). Steven Timcke, with his extensive experience and proven track record in financial leadership, who has taken on the role of CFO at OIA last year. His expertise will be invaluable as we continue to grow and evolve as a company bringing more experienced leaders.

Steven brings over 25 years of experience building long-lasting and trusting relationships with owners and stakeholders as Financial Director and CFO. He has extensive experience in the manufacturing and engineering sectors and has served as a Portfolio Finance Director and seasoned CFO at The FD & CFO Centre in Oxford. Steven's wealth of experience and his proven track record in financial leadership will be invaluable as we continue to grow and evolve as a company.


We are also thrilled to introduce Dr. Alfonso Ferrandez as our new Chief Technology Officer (CTO). Alfonso holds a Ph.D. in Computational BioFluid Dynamics from Leeds and has over 25 years of experience in highly technical and strategic positions. His impressive career includes designing and building one of the largest IoT networks in the UK as CTO of OVO Energy and its Kaluza division and designing and building the entire patient triaging platform as a medical device Class IIa/IIb of DoctorLink, which he took from 10k users to 15 million when it was sold. Alfonso's expertise in medical device integration, advanced computer vision, and data fusion algorithms will be instrumental in driving our technological innovation.

Alfonso’s Ph.D. work, supported by the NHS, led to an algorithm used by NASA today to vet astronauts’ health. We are excited to have both Steven and Alfonso on board and look forward to the invaluable contributions they will make to our team.

“It's days like today, when I am deep into one of my favourite subjects, MedTech, with some of the people that I most admire in the industry, like Hector Zenil and the team at Oxford Immune Algorithmics, that make me realise that there is hope for the human race, and that with the help of AI, we will be able to address some of the biggest challenges in the #healthcare space… I hope you are ready for a wild ride, because things are about to get very interesting!

Alfonso Ferrandez, CTO, Oxford Immune Algorithmics

.



About Oxford Immune Algorithmics

Incubated by the University of Oxford, OIA is a deep-tech start-up that aims to responsibly apply Artificial General Intelligence (AGI), Algocyte
®, to eradicate all preventable diseases by enabling predictive, precise, and personalised medicine to everyone.

Previous
Previous

OIA Welcomes New Strategic Investor Mark Stevenson, & New Board Advisor, Abel Archundia, to Drive Growth & Innovation in AI-Powered Precision Medicine

Next
Next

Oxford Immune Algorithmics’ CEO participates at the Ferguson Summit with fellow founders and investors in Florida